Int. J. Environ. Res. Public Health 2013, 10(2), 590-605; doi:10.3390/ijerph10020590
High Dosage Folic Acid Supplementation, Oral Cleft Recurrence and Fetal Growth
1
Department of Health Management and Policy, University of Iowa, Iowa City, IA 52242, USA
2
Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul 90035-903, Brazil
3
RTI International, Research Triangle Park, NC 27709, USA
4
Hospital de Reabilitação de Anomalias Craniofaciais, Bauru, Sao Paulo 17.043-900, Brazil
5
Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC 29208, USA
6
Centro de Atendimento Integral ao Fissurado Lábio Palatal, Curitiba, Paraná 81.050-000, Brazil
7
Instituto Materno Infantil Prof. Fernando Figueira-CADEFI/IMIP, Recife, Pernambuco 50070-550, Brazil
8
Hospital Santo Antônio: Obras Sociais Irmã Dulce, Salvador, Bahia 40.415-000, Brazil
9
Genetic Counseling Service, São Paulo State University, Botucatu, Sao Paulo 18618-000, Brazil
10
Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA
*
Author to whom correspondence should be addressed.
Received: 8 October 2012 / Revised: 25 January 2013 / Accepted: 25 January 2013 / Published: 4 February 2013
(This article belongs to the Special Issue Birth Defect Prevention)
Abstract
Objectives: To evaluate the effects of folic acid supplementation on isolated oral cleft recurrence and fetal growth. Patients and Methods: The study included 2,508 women who were at-risk for oral cleft recurrence and randomized into two folic acid supplementation groups: 0.4 and 4 mg per day before pregnancy and throughout the first trimester. The infant outcome data were based on 234 live births. In addition to oral cleft recurrence, several secondary outcomes were compared between the two folic acid groups. Cleft recurrence rates were also compared to historic recurrence rates. Results: The oral cleft recurrence rates were 2.9% and 2.5% in the 0.4 and 4 mg groups, respectively. The recurrence rates in the two folic acid groups both separately and combined were significantly different from the 6.3% historic recurrence rate post the folic acid fortification program for this population (p = 0.0009 when combining the two folic acid groups). The rate of cleft lip with palate recurrence was 2.9% in the 0.4 mg group and 0.8% in the 4 mg group. There were no elevated fetal growth complications in the 4 mg group compared to the 0.4 mg group. Conclusions: The study is the first double-blinded randomized clinical trial (RCT) to study the effect of high dosage folic acid supplementation on isolated oral cleft recurrence. The recurrence rates were similar between the two folic acid groups. However, the results are suggestive of a decrease in oral cleft recurrence compared to the historic recurrence rate. A RCT is still needed to identify the effect of folic acid on oral cleft recurrence given these suggestive results and the supportive results from previous interventional and observational studies, and the study offers suggestions for such future studies. The results also suggest that high dosage folic acid does not compromise fetal growth. View Full-TextKeywords:
oral clefts; cleft lip; cleft palate; birth defects; folic acid; vitamins; prevention; pregnancy; nutrition; Brazil
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
Scifeed alert for new publications
Never miss any articles matching your research from any publisher- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Wehby, G.L.; Félix, T.M.; Goco, N.; Richieri-Costa, A.; Chakraborty, H.; Souza, J.; Pereira, R.; Padovani, C.; Moretti-Ferreira, D.; Murray, J.C. High Dosage Folic Acid Supplementation, Oral Cleft Recurrence and Fetal Growth. Int. J. Environ. Res. Public Health 2013, 10, 590-605.
Related Articles
Article Metrics
Comments
[Return to top]
Int. J. Environ. Res. Public Health
EISSN 1660-4601
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert